C
Calcitonin
Calcitonin is a peptide hormone secreted primarily by parafollicular C cells of the thyroid gland. It is released in response to increased extracellular calcium and acts mainly on bone and kidneys, including inhibition of osteoclastic bone resorption, although its role in normal adult human calcium homeostasis is less prominent than that of parathyroid hormone and vitamin D.
Region-
SystemEndocrine System
Calcitonin is a peptide hormone produced primarily by parafollicular cells, also called C cells, of the thyroid gland. Its secretion increases when extracellular calcium concentrations rise, and its principal physiological actions tend to reduce movement of calcium from bone into extracellular fluid.
Calcitonin acts most prominently on the skeleton, where it inhibits the activity of osteoclasts, the cells responsible for bone resorption. It also has renal effects that can influence the handling of calcium and phosphate.
Although calcitonin participates in mineral metabolism, its importance in maintaining normal calcium concentration in adult humans is considerably less than that of parathyroid hormone (PTH) and vitamin D. This distinction is important because calcitonin is often presented as a simple physiological antagonist of PTH, while human calcium homeostasis is more complex.
Hormone Classification
Calcitonin is a peptide hormone. Mature human calcitonin consists of 32 amino acids.
As a peptide hormone, calcitonin is synthesized as a larger precursor, processed intracellularly, stored in secretory vesicles, and released by regulated exocytosis.
Site of Production
Calcitonin is produced primarily by the parafollicular C cells of the thyroid gland.
These endocrine cells are anatomically and functionally distinct from the thyroid follicular cells that produce thyroxine (T4) and triiodothyronine (T3).
Thyroid Gland
The thyroid gland is an endocrine organ located in the anterior neck, typically extending across the lower cervical region on either side of the upper trachea.
Its two major endocrine cell populations are follicular cells and parafollicular C cells.
Thyroid Endocrine Cell Types
| Cell Type | Major Hormone | Primary Function |
|---|---|---|
| Follicular cells | T4 and T3 | Regulation of metabolism, growth, development, and thermogenesis |
| Parafollicular C cells | Calcitonin | Modulation of calcium and bone metabolism |
Parafollicular C Cells
Parafollicular cells are endocrine cells located within the thyroid gland but outside the follicular lumen.
They may occur individually or in small groups in association with thyroid follicles. Unlike follicular cells, C cells do not contribute to the formation of thyroid colloid.
Relationship to Thyroid Follicles
Thyroid follicles are spherical structures lined by follicular epithelial cells and filled with colloid containing thyroglobulin.
C cells are positioned within the thyroid parenchyma and are closely associated with follicles but generally do not contact the follicular lumen.
Histological Appearance
C cells generally appear larger and paler than surrounding thyroid follicular cells on routine histological preparations.
They contain secretory granules that store calcitonin and other peptide products.
Embryological Origin
Parafollicular C cells become incorporated into the developing thyroid through the ultimobranchial bodies, which are associated with the caudal pharyngeal pouch complex.
Current developmental evidence indicates that mammalian thyroid C cells ultimately arise from endodermal progenitors, despite their historical description as neural crest-derived cells.
Calcitonin Synthesis
Calcitonin is encoded by the CALCA gene and synthesized initially as a larger precursor molecule.
Intracellular processing produces mature calcitonin, which is stored within secretory granules until an appropriate stimulus triggers release.
Calcitonin Gene
The CALCA gene is notable because tissue-specific RNA processing can generate different peptide products.
In thyroid C cells, processing favors production of calcitonin, whereas alternative processing in neural tissues can generate calcitonin gene-related peptide (CGRP).
Calcitonin Gene-Related Peptide
CGRP is structurally related to calcitonin but has distinct physiological functions, particularly within sensory and cardiovascular pathways.
Calcitonin and CGRP therefore illustrate how alternative processing of transcripts from the same gene can generate functionally different signaling peptides.
Regulation of Calcitonin Secretion
The major physiological regulator of calcitonin secretion is the concentration of extracellular ionized calcium.
Increasing extracellular calcium stimulates C cells and increases calcitonin release.
High Calcium and Calcitonin
When extracellular calcium rises, calcitonin secretion increases.
The resulting hormone response tends to oppose further increases in extracellular calcium, particularly by reducing osteoclastic bone resorption.
Low Calcium and Calcitonin
When extracellular calcium is low, calcitonin secretion decreases.
Under these conditions, the PTH-vitamin D system becomes considerably more important for restoring extracellular calcium.
Calcium-Sensing Receptor
Parafollicular C cells express the calcium-sensing receptor (CaSR), allowing them to respond to changes in extracellular calcium concentration.
Activation of calcium-sensing pathways by increased calcium promotes calcitonin secretion.
Calcium-Calcitonin Relationship
| Extracellular Calcium | Calcitonin Response |
|---|---|
| Increases | Calcitonin secretion increases |
| Decreases | Calcitonin secretion decreases |
Gastrointestinal Hormones and Calcitonin
Calcitonin secretion can also be influenced by gastrointestinal signals associated with food intake.
This relationship may contribute to anticipatory regulation of calcium handling when dietary calcium enters the body.
Calcitonin Receptor
Calcitonin acts through the calcitonin receptor (CTR), a G protein-coupled receptor.
The receptor is expressed prominently on osteoclasts and is also present in the kidney and other tissues.
Calcitonin Receptor Signaling
Activation of the calcitonin receptor can stimulate intracellular signaling pathways involving cyclic AMP and other second messengers.
In osteoclasts, these signals rapidly reduce the cellular activity required for bone resorption.
Major Target Organs
The most important target tissues for understanding calcitonin physiology are bone and kidney.
| Target | Major Effect |
|---|---|
| Bone | Inhibits osteoclast-mediated bone resorption |
| Kidney | Can increase renal excretion of calcium and phosphate |
Calcitonin and Bone
Bone is the body's major mineral reservoir and contains the overwhelming majority of total body calcium.
Calcitonin can reduce the release of skeletal calcium by inhibiting osteoclast activity.
Osteoclasts
Osteoclasts are large multinucleated cells specialized for bone resorption.
They attach to bone surfaces and create specialized resorption compartments in which mineral is dissolved and organic matrix is degraded.
Calcitonin Action on Osteoclasts
Osteoclasts express calcitonin receptors and can respond rapidly to circulating calcitonin.
Calcitonin reduces osteoclast motility and resorptive activity, thereby decreasing the release of calcium and phosphate from bone mineral.
Bone Resorption
Bone resorption is the process through which osteoclasts remove mineralized bone tissue.
Inhibition of this process is the principal mechanism underlying calcitonin's acute skeletal effect.
Calcitonin and Osteoblasts
Calcitonin's best-established direct skeletal target is the osteoclast rather than the osteoblast.
Changes in osteoclast activity can nevertheless influence the coupled process of bone remodeling and therefore indirectly affect osteoblast-mediated bone formation.
Bone Remodeling
Bone remodeling requires coordinated activity between osteoclasts and osteoblast-lineage cells.
Calcitonin can modify this remodeling process by suppressing the resorptive component, particularly when osteoclastic activity is elevated.
Calcitonin and the Kidney
Calcitonin also acts on the kidneys and can influence renal mineral handling.
Its renal effects tend to promote excretion of calcium and phosphate, although these actions are generally less important for routine calcium homeostasis than the renal effects of PTH.
Renal Calcium Handling
Calcitonin can reduce tubular calcium reabsorption under appropriate physiological or pharmacological conditions, increasing calcium excretion in urine.
This action is consistent with its overall tendency to oppose elevations in extracellular calcium.
Renal Phosphate Handling
Calcitonin can also decrease renal phosphate reabsorption and promote phosphaturia.
The magnitude and physiological importance of this response depend on the hormonal and mineral state of the individual.
Effects of Calcitonin
| Process | Effect |
|---|---|
| Osteoclast activity | Decreases |
| Bone resorption | Decreases |
| Release of calcium from bone | Decreases |
| Release of phosphate from bone | Decreases |
| Renal calcium excretion | Can increase |
| Renal phosphate excretion | Can increase |
| Extracellular calcium | Tends to decrease |
Calcitonin and Calcium Homeostasis
Calcitonin is frequently described as a calcium-lowering hormone because it is secreted in response to elevated calcium and inhibits osteoclastic bone resorption.
However, normal adult humans can generally maintain calcium homeostasis despite major changes in calcitonin availability. This demonstrates that calcitonin is not the dominant day-to-day regulator of plasma calcium.
Physiological Importance in Humans
The relatively modest role of calcitonin in adult human calcium homeostasis can be demonstrated clinically. Removal of the thyroid gland eliminates the principal source of circulating calcitonin, yet this alone does not usually cause major chronic hypercalcemia.
Conversely, very high calcitonin concentrations can occur in medullary thyroid carcinoma without necessarily producing profound hypocalcemia.
Calcitonin and Parathyroid Hormone
Calcitonin and parathyroid hormone have several opposing effects, particularly on bone resorption, but they should not be regarded as equally important mirror-image regulators.
PTH is essential for maintaining extracellular calcium, while calcitonin has a more limited modulatory role in adult humans.
Calcitonin Versus PTH
| Feature | Calcitonin | PTH |
|---|---|---|
| Source | Thyroid C cells | Parathyroid chief cells |
| Major secretory stimulus | Elevated extracellular calcium | Reduced extracellular calcium |
| Bone resorption | Inhibits osteoclast activity | Can increase resorption through osteoblast-lineage signaling |
| Renal calcium handling | Can increase calcium excretion | Increases calcium conservation |
| Renal phosphate handling | Can increase phosphate excretion | Strongly increases phosphate excretion |
| Calcitriol production | Not a principal stimulatory action | Stimulates renal calcitriol formation |
| Importance in adult calcium homeostasis | Limited or modulatory | Major |
Calcitonin and Vitamin D
Vitamin D and calcitonin influence mineral physiology through different mechanisms.
Active vitamin D promotes intestinal calcium and phosphate absorption and participates extensively in bone and mineral homeostasis, whereas calcitonin primarily suppresses osteoclastic resorption when activated.
Calcitonin, PTH, and Vitamin D
| Hormone | Primary Source | Major Mineral Function |
|---|---|---|
| Calcitonin | Thyroid C cells | Inhibits osteoclast-mediated bone resorption |
| PTH | Parathyroid chief cells | Maintains extracellular calcium and regulates renal phosphate handling |
| Calcitriol | Activated primarily in kidney | Increases intestinal calcium and phosphate absorption |
Calcitonin During Growth
The potential contribution of calcitonin to mineral metabolism may be more relevant during periods of active skeletal remodeling and high calcium flux.
Its precise importance varies according to physiological state and is less clearly defined than the roles of PTH and vitamin D.
Calcitonin During Pregnancy and Lactation
Pregnancy and lactation require substantial adaptations in maternal calcium metabolism to support fetal skeletal mineralization and milk production.
Calcitonin may contribute to the complex hormonal regulation that protects maternal skeletal mineral stores during periods of increased calcium demand, although multiple endocrine systems participate in these adaptations.
Medullary Thyroid Carcinoma
Medullary thyroid carcinoma (MTC) is a malignant neoplasm arising from thyroid parafollicular C cells.
Because these cells normally produce calcitonin, medullary thyroid carcinoma can secrete large amounts of the hormone.
Calcitonin as a Tumor Marker
Serum calcitonin is an important biochemical marker in the evaluation and follow-up of medullary thyroid carcinoma.
Changes in calcitonin concentration can provide information about C-cell tumor burden, persistence, recurrence, or response to treatment when interpreted in the appropriate clinical context.
C-Cell Hyperplasia
C-cell hyperplasia refers to an increased number of thyroid parafollicular cells.
It can occur in association with hereditary forms of medullary thyroid carcinoma and may represent a precursor lesion in genetically predisposed individuals.
Multiple Endocrine Neoplasia Type 2
Hereditary medullary thyroid carcinoma can occur as part of multiple endocrine neoplasia type 2 (MEN2).
These syndromes are associated with pathogenic variants involving the RET proto-oncogene and can include additional endocrine tumors depending on the specific syndrome.
Calcitonin Measurement
Calcitonin is not generally measured as a routine test of calcium homeostasis.
Its greatest clinical importance as a laboratory marker is associated with disorders involving thyroid C cells, particularly medullary thyroid carcinoma.
Elevated Calcitonin
An elevated calcitonin concentration is not by itself diagnostic of medullary thyroid carcinoma.
Results must be interpreted in relation to assay characteristics, clinical context, thyroid findings, medications, renal function, and other potential causes of altered calcitonin concentrations.
Therapeutic Calcitonin
Pharmacological calcitonin has been used because of its ability to inhibit osteoclast activity and lower calcium under selected circumstances.
Historically, therapeutic preparations have included human calcitonin and salmon calcitonin, with salmon calcitonin having greater potency and a longer duration of action at human calcitonin receptors.
Calcitonin and Hypercalcemia
Calcitonin can lower calcium relatively rapidly by suppressing osteoclastic bone resorption and increasing renal calcium excretion.
Its effect can diminish with continued administration because target tissues develop tachyphylaxis, limiting its usefulness as sustained monotherapy for hypercalcemia.
Calcitonin and Paget Disease
Calcitonin has historically been used to suppress excessive osteoclastic activity in Paget disease of bone.
Other antiresorptive therapies are now generally more prominent, but the response illustrates calcitonin's direct inhibitory action on osteoclasts.
Calcitonin and Osteoporosis
Calcitonin has also been used as an antiresorptive treatment in osteoporosis.
Its role has become limited compared with other available therapies, but its pharmacological effects remain closely related to inhibition of osteoclast-mediated bone resorption.
Calcitonin and Bone Pain
Calcitonin has been associated with analgesic effects in some disorders involving bone, although the mechanisms are not explained solely by changes in calcium metabolism.
This property has contributed to selected historical and clinical uses of calcitonin preparations.
Thyroidectomy and Calcitonin
Total thyroidectomy removes the principal source of circulating calcitonin.
The absence of major chronic disturbances of serum calcium caused solely by calcitonin deficiency demonstrates that other regulatory systems, particularly PTH and vitamin D, are capable of maintaining calcium homeostasis.
Clinical Importance of Thyroid Anatomy
The distinction between thyroid follicular cells and C cells is important clinically because tumors arising from these cell populations differ substantially.
Most differentiated thyroid cancers arise from follicular epithelial cells, whereas medullary thyroid carcinoma originates from calcitonin-producing C cells.
Follicular Cells Versus C Cells
| Feature | Follicular Cells | C Cells |
|---|---|---|
| Location | Form thyroid follicular epithelium | Located parafollicularly within thyroid tissue |
| Major secretory products | T4 and T3 | Calcitonin |
| Relationship to colloid | Directly contact follicular lumen | Generally do not contact follicular lumen |
| Major physiological role | Thyroid hormone synthesis | Modulation of mineral metabolism |
| Characteristic malignancy | Follicular-derived thyroid carcinomas | Medullary thyroid carcinoma |
Calcitonin Response to Hypercalcemia
| Step | Event |
|---|---|
| 1 | Extracellular ionized calcium increases |
| 2 | Calcium-sensitive signaling in thyroid C cells increases |
| 3 | Calcitonin secretion increases |
| 4 | Calcitonin binds receptors on osteoclasts |
| 5 | Osteoclast activity decreases |
| 6 | Release of calcium from bone decreases |
| 7 | Renal mineral excretion can also increase |
Key Features of Calcitonin
| Feature | Key Point |
|---|---|
| Hormone class | Peptide hormone |
| Length | 32 amino acids |
| Primary source | Thyroid parafollicular C cells |
| Major secretory stimulus | Elevated extracellular calcium |
| Major receptor | Calcitonin receptor |
| Important skeletal target | Osteoclast |
| Bone resorption | Decreases |
| Calcium release from bone | Decreases |
| Renal calcium excretion | Can increase |
| Renal phosphate excretion | Can increase |
| Overall calcium effect | Tends to lower extracellular calcium |
| Importance in adult calcium homeostasis | Limited compared with PTH and vitamin D |
| Major clinical association | Medullary thyroid carcinoma |
| Gene | CALCA |
Anatomical and Physiological Importance
Calcitonin demonstrates the presence of two functionally distinct endocrine cell systems within the thyroid gland. Follicular cells produce thyroid hormones and organize themselves into colloid-containing follicles, while parafollicular C cells produce calcitonin and occupy positions outside the follicular lumen.
C cells continuously respond to the extracellular mineral environment. When ionized calcium rises, calcium-sensitive signaling stimulates calcitonin secretion. Circulating calcitonin then reaches target tissues, particularly the skeleton, where osteoclasts express calcitonin receptors.
Activation of these receptors rapidly suppresses osteoclastic activity and reduces bone resorption. As a result, movement of calcium and phosphate from skeletal mineral stores into extracellular fluid decreases. Calcitonin can also alter renal handling of these minerals and promote their excretion.
Despite these actions, calcitonin is not the principal regulator of adult human calcium concentration. The PTH-vitamin D system provides the dominant mechanisms required to defend extracellular calcium, while calcitonin functions more as a modulatory calcium-lowering signal.
The hormone has particular clinical importance because its cells of origin give rise to medullary thyroid carcinoma. Calcitonin secretion by these tumors provides a useful biochemical connection between normal thyroid C-cell anatomy and the diagnosis and monitoring of C-cell neoplasia.
Through its secretion by parafollicular C cells, responsiveness to extracellular calcium, direct inhibition of osteoclasts, renal effects, and association with medullary thyroid carcinoma, calcitonin provides an important link between thyroid anatomy, skeletal remodeling, mineral physiology, and endocrine pathology.
Published on October 1, 2026
Last updated on October 1, 2026
Last updated on October 1, 2026